Network Theme: Continuous blood processing for patient specific therapies - Dr Robert Barker (University of Kent)

This video is the third talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021.

Network Theme: Continuous blood processing for patient specific therapies - Dr Robert Barker (University of Kent)

Bio: Dr Robert Barker is an Associate Professor in Chemistry in the School of Physical Sciences, School Director of Public Engagement, project lead for the ‘Future Human’ Signature Research, University of Kent (UoK). He is a Royal Society Industrial Fellow and the PI of the trans-disciplinary EPSRC project Optimising Me Manufacturing Systems [EP/R022534/1], exploring continuous blood processing for healthcare and developing a healthcare micro-factory that provides on-the-body manufacturing of therapeutics, continuously and in response to the body’s needs. His work focuses on the whole blood processing and the development of a manufacturing system for T-cell immunotherapies which present a cure for some of the most aggressive forms of cancer (acute lymphoblastic leukaemia and chronic lymphoblastic leukaemia). His research is at the interface of industry and the NHS to meet their needs for continuous blood monitoring and to help the shift away from the current one-size-fits-all approach to deliver patient-specific therapies.

Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/

This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1

YouTube Link: https://youtu.be/T4UVEOM1cZU